Literature DB >> 7081793

Phenylpropanolamine: a potentially hazardous drug.

E Bernstein, B M Diskant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7081793     DOI： 10.1016/s0196-0644(82)80130-3

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN： 0196-0644            Impact factor:   5.721


× No keyword cloud information.
  9 in total

1.  Cerebral infarction after excessive use of nasal decongestants.

Authors:  J Montalbán; L Ibañez; C Rodriguez; M Lopez; J Sumalla; A Codina
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

2.  Decongestant-induced hypertensive crisis.

Authors:  S A Backlin
Journal:  Can Fam Physician       Date:  1993-02       Impact factor: 3.275

3.  Fatal overdosage of phenylpropanolamine.

Authors:  A W Logie; C M Scott
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-08

4.  Phenylpropanolamine and cerebral hemorrhage.

Authors:  J R McDowell; H J LeBlanc
Journal:  West J Med       Date:  1985-05

5.  Histamine and Seizures : Implications for the Treatment of Epilepsy.

Authors:  H Yokoyama; K Iinuma
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

Review 6.  Non-prescription sympathomimetic agents and hypertension.

Authors:  S S Chua; S I Benrimoj
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

Review 7.  Drug interactions in hypertensive patients. Pharmacokinetic, pharmacodynamic and genetic considerations.

Authors:  Y W Lam; A M Shepherd
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

Review 8.  Pharmacologic treatment of rhinitis.

Authors:  F E Simons; K J Simons
Journal:  Clin Rev Allergy       Date:  1984-08

Review 9.  The recent advancement of low-dimensional nanostructured materials for drug delivery and drug sensing application: A brief review.

Authors:  Hamidur Rahman; Md Rakib Hossain; Tahmina Ferdous
Journal:  J Mol Liq       Date:  2020-09-30       Impact factor: 6.165
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.